N. Lods

Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection.

H. Marti, M. Schumacher, M. Ermolli, 2003, Transplant immunology.

Metalloprotease Meprinβ in Rat Kidney: Glomerular Localization and Differential Expression in Glomerulonephritis

J. Pippin, H. Marti, B. Oneda, 2008, PloS one.

Matrix metalloproteinase inhibitors cause cell cycle arrest and apoptosis in glomerular mesangial cells.

J. Duffield, T. Brunner, H. Marti, 2001, The Journal of pharmacology and experimental therapeutics.

Cultured gastrointestinal smooth muscle cells: cell response to contractile agonists depends on their phenotypic state

J. Bali, R. Magous, F. Michel, 2004, Cell and Tissue Research.

A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease

Rupert Lanzenberger, Gianluigi Forloni, Aiman Abrahim, 2006, Clinical pharmacology and therapeutics.

Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis.

B. Vogt, F. Frey, A. Kappeler, 2003, Journal of the American Society of Nephrology : JASN.

Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets.

R. Lindberg, C. V. Kooten, A. Kappeler, 2006, Kidney international.

Metalloprotease meprin beta in rat kidney: glomerular localization and differential expression in glomerulonephritis

C. Becker-Pauly, D. Lottaz, Daniel Ambort, 2020 .